asthma

By Laura Lovett 03:10 pm July 7, 2020
Novartis and respiratory health company Propeller Health, a ResMed subsidiary, have teamed up to co-package the latter’s digital health platform with the pharma giant’s new asthma medication Enerzair Breezhaler.  This news come shortly after the product landed European Commission clearance. The co-packaged product will be launching in the EU during 2020. However, it is not yet available in the U....
By Laura Lovett 03:15 pm June 10, 2020
Over the last few months respiratory health has become a major area of focus within the medical community and beyond, as COVID-19 on takes its toll. However, respiratory conditions have long impacted the American public. In fact, the CDC reports that 19.2 million US adults have asthma.  As in many areas of health, today we are seeing the rise of digital for monitoring and treating respiratory...
By Dave Muoio 03:19 pm May 26, 2020
Digital respiratory health company Propeller Health has received 510(k) clearance for a sensor and app intended for use with AstraZeneca's Symbicort inhaler for asthma and COPD, the company announced today. The tool – which, according to the agency, was submitted to the agency in September and greenlit in late March – was developed in a previously unannounced partnership with the Cambridge,...

Credit: MySpira

By Leontina Postelnicu 11:38 am August 23, 2019
A new app for asthma sufferers promises to provide another means of improving training and awareness of correct inhaler technique by using gamification and an augmented reality functionality released by Google (ARCore) and Apple (ARKit). Called MySpira, the app, which aims to help children aged six to 13, was developed by UK-based digital agency Orbital Media in conjunction with the University of...
By Dave Muoio 11:47 am May 28, 2019
This month’s news that Apple had picked up the patent rights for a passive health monitoring system from startup Tueo Health does not appear to the only business occurring between the two companies. On Friday, CNBC reported that the consumer tech company had also outright acquired the small respiratory health company for an undisclosed sum. Tueo Health’s website was pulled down at some point late...
By Dave Muoio 04:27 pm May 13, 2019
Apple has acquired the worldwide rights to a patent describing a means of monitoring a user’s health while they sleep, without the use of a smart device like the iPhone, iPad or Apple Watch. The patent, registered with the European Patent Office and spotted yesterday by Patently Apple, incorporates sensors placed near or remote to the patient to monitor individual, environmental, physiological...
By Jonah Comstock 02:41 pm March 29, 2019
At MEDinIsrael 2019 this week, a conference in Tel Aviv sponsored by the Israeli Export Institute, Dr. Lena Granovsky, director of analytics and big data at Teva Pharmaceuticals, spoke on and off stage about the work the top Israeli pharma company has been doing in digital health. These topics included the company's recently FDA-cleared smart inhaler ProAir Digihaler, as well as more broad...
By Laura Lovett 01:50 pm February 25, 2019
This morning Spirosure, a health tech company focused on respiratory conditions, announced that its latest product the Fenom Pro Asthma Monitor has landed FDA clearance. The provider-facing technology enables clinicians to measure the fraction of exhaled nitric oxide (FeNO), an indicator of airway inflammation, in their patient’s breath. The technology uses proprietary algorithms to detect the...
By Dave Muoio 12:46 pm January 23, 2019
While recent news of international product launches and recent M&As might suggest a cutthroat market, new data released this week by Research2Guidance suggest that there is still plenty of room in the digital respiratory health sector for both existing and new market players. According to “The Global Digital Respiratory Solutions Market 2009-2023” report, roughly 210 million asthma and COPD...
By Jonah Comstock 03:32 pm January 10, 2019
Respiratory health company Propeller Health, which was recently acquired by ResMed for $225 million, announced this week in San Francisco a partnership with Walgreens and a new feature for users of its platform. The new feature, called My Pharmacy, will allow Propeller’s end users, patients with asthma and COPD, to connect to pharmacy services without leaving the Propeller app. At launch, users...